2009 News Releases

Dec 30, 2009:
iCo Therapeutics Grants Options to Directors, Officers and Employees

Dec 11, 2009:
iCo Therapeutics Provides Phase 1 DME Clinical Trial Update and Phase 2 Trial Guidance

Dec 3, 2009:
iCo Therapeutics iCo-007 Overview to be Presented at the 8th International Symposium on Ocular Pharmacology and Therapeutics

Nov 26, 2009:
iCo Therapeutics Q3 2009 Financial Results

Nov 20, 2009:
iCo Therapeutics Completes Final Tranche of $4,000,000 Brokered Private Placement

Oct 30, 2009:
iCo Therapeutics Completes First Tranche of Brokered Private Placement

Oct 20, 2009:
iCo Therapeutics Announces $4,000,000 Brokered Private Placement

Sep 24, 2009:
iCo Therapeutics Signs Collaboration Agreement with The Consortium for Parasitic Drug Development

Aug 21, 2009:
iCo Therapeutics Q2 2009 Financial Results

Jul 21, 2009:
iCo Therapeutics Appoints Infectious Disease MD to Scientific Advisory Board

Jul 16, 2009:
iCo Therapeutics Closes Non-Brokered Private Placement

Jul 7, 2009:
iCo Therapeutics Diabetic Macular Edema Clinical Trial Update

Jul 2, 2009:
iCo Therapeutics Publishes Review of Diabetic Retinopathy Treatment

Jun 25, 2009:
iCo Therapeutics Positive Oral Amphotericin B Data Published in the Journal of Infectious Diseases

Jun 8, 2009:
Shareholders Approve All Resolutions at iCo Therapeutics Annual General Meeting

May 29, 2009:
iCo Therapeutics Q1 2009 Financial Results

Apr 30, 2009:
iCo Therapeutics Year-End 2008 Financial Results

Apr 29, 2009:
iCo Therapeutics to Present at BioFinance 2009

Mar 23, 2009:
iCo Therapeutics Oral Anti-Parasitic Drug to be Presented at Global Health Symposia

Mar 17, 2009:
iCo Therapeutics iCo-007 Second Cohort Results to be Presented at Cleveland Clinic Ocular Conference

Feb 20, 2009:
iCo Therapeutics Grants Options to New Directors

Feb 19, 2009:
iCo Therapeutics iCo-007 Results to be Presented at Prestigious Ocular Conference

Feb 18, 2009:
iCo Therapeutics Oral Amphotericin B Published in Leading Journal

Feb 9, 2009:
iCo Therapeutics Closes $1.3 Million Private Placement

Jan 30, 2009:
iCo Therapeutics Closes First Tranche of Non-Brokered Private Placement